2021 annual financial data
Tenax Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -32,728,241 USD and net income was -32,474,358 USD.
Operating cash flow was -10,856,203 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -32,728,241 USD
- Net income
- -32,474,358 USD
- Operating cash flow
- -10,856,203 USD